Good evening :)
$
Acumen Pharmaceuticals Inc

Acumen Pharmaceuticals Inc

ABOS

NASDAQ
$2.841.55% (-0.04)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Biotechnology

Micro Cap

With a market cap of $201.8M the stock is ranked 4233

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

PB
PB

Close price divided by the book value per share at the end of the most recent quarter

3.69
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-1.64
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

0%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

Analyst Ratings & Forecast
Analyst Ratings & Forecast

Based on 5 analysts' reports

Buy
5 analysts
Hold
0 analyst
Sell
0 analyst

Analysts expect a +165.23% price upside over the next year

Current Price$2.84
Target Price$7.4

Company Profile

Peers

Peers

P/E Ratio
73.73
73.73
1Y Return
21.16%
21.16%
Buy Reco %
57.14
57.14
P/E Ratio
23.68
23.68
1Y Return
37.87%
37.87%
Buy Reco %
46.87
46.87
P/E Ratio
1Y Return
29.99%
29.99%
Buy Reco %
63.33
63.33
P/E Ratio
30.27
30.27
1Y Return
30.87%
30.87%
Buy Reco %
52.94
52.94
P/E Ratio
19.64
19.64
1Y Return
35.36%
35.36%
Buy Reco %
76.00
76.00

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareBiotechnology
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Acumen Pharmaceuticals Inc -3.69-
AbbVie Inc73.7350.450.52
Amgen Inc23.6817.452.27

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

-26.4
-25.1
-20.7
-32.7
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue0000.17000000
Net Income-14.87-20.53-29.76-37.15-28.79-40.95-26.45-25.13-20.73-32.71
Net Profit Margin----20873.03%------

Frequently asked questions

Frequently asked questions

  1. Acumen Pharmaceuticals Inc (ABOS) share price today is $2.84 as of September 16, 2026 at 9:46 PM IST. The stock touched a day high of $2.95 and a day low of $2.84.

  2. Acumen Pharmaceuticals Inc stock trades on NASDAQ under the ticker symbol ABOS.

  3. Acumen Pharmaceuticals Inc's market capitalization is $201.76M as of September 16, 2026 at 9:46 PM IST.

  4. Acumen Pharmaceuticals Inc's price-to-earnings (P/E) ratio is N/A as of September 16, 2026.

  5. Acumen Pharmaceuticals Inc's price-to-book (P/B) ratio is 3.69 as of September 16, 2026.

  6. Yes, You can buy Acumen Pharmaceuticals Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Acumen Pharmaceuticals Inc shares in three steps: 1. Search Acumen Pharmaceuticals Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Acumen Pharmaceuticals Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Acumen Pharmaceuticals Inc (ABOS) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 3.5149 shares at the current price of $2.84.

Loading...